Aethlon Medical Inc.

Company Snapshot

Founded: 1999

Entity Type: Public

Employees: 14

Region: U.S.

Headquarter: California, U.S.

Key Geographics: U.S.

Corporate Address: 11555 Sorrento Valley Road, Suite 203, San Diego, California 92121 U.S. Tel. +1-619-941-0360 www.aethlonmedical.com

Company Overview

Aethlon Medical, Inc. is a medical therapeutic company focused on developing products for cancer and deadly infectious disease treatment. Its lead therapeutic candidate is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device designed to treat cancer and fatal viral infections.

In cancer, the Hemopurifier is designed to eliminate the presence of circulating tumor (CT)-derived exosomes that facilitate immune suppression, seed the spread of metastasis, and prevent the benefit of leading cancer therapies.

On September 12, 2019, the NCI awarded Aethlon Medical a Small Business Innovation Research Program (SBIR) Phase II Award Contract for NIH/NCI Topic 359, entitled “A Device Prototype for Isolation of Melanoma Exosomes for Diagnostics and Treatment Monitoring.” The Award Contract amount was $1.9 million and, as amended, ran from September 16, 2019, through September 15, 2022.

Financial Highlights (FY 2023)

Net Revenue: ***

Total Current Liabilities: ***

Total Current Assets: ***

R&D expenses: ***

Operating Income: ***

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member